Academic Journal
Q1Clinical Pharmacology & Therapeutics
About Clinical Pharmacology & Therapeutics
Clinical Pharmacology & Therapeutics is a scholarly journal published by Wiley-Blackwell. SCImago 2025 places it in Q1 with an SJR of 1.856 and an H-index of 226.
Its listed coverage is 1960-2026 and its research categories include Pharmacology (Q1); Pharmacology (medical) (Q1). The 2025 dataset reports 373 documents and 4526 citations across the latest three-year reporting window.
Journal Metrics
Metrics can change by reporting year. Verify time-sensitive values with the publisher or indexing service.
Aims & Scope
The journal publishes research related to Pharmacogenetics and Drug Metabolism, Pharmaceutical studies and practices, Cancer Treatment and Pharmacology, Pharmacological Effects and Toxicity Studies, Drug Transport and Resistance Mechanisms, Antibiotics Pharmacokinetics and Efficacy.
Recent Research Articles
Latest publications matched automatically by ISSN.
How to Optimize Healthy Volunteer Screening and Enrolment in Clinical Trials: A Qualitative and Quantitative Approach to Evaluate Processes and Healthy Volunteers' Perceptions
Evelyn Krohmer, Manuela König, Cathrin J. Vogt, Marina Streckebein et al.
2026-09-09 · DOI: 10.1002/cpt.70462Phase I Evaluation of Siltartoxatug, a First‐in‐Class Anti‐Tetanus Monoclonal Antibody: Safety, Pharmacokinetics and Pharmacodynamics in Healthy Australian and Chinese Populations
Xinyu Liu, Zhigang Liu, Xiaohu Kuang, Yueming Wang et al.
2026-09-09 · DOI: 10.1002/cpt.70467Toward Fit‐for‐Purpose Data for Drug Assessment in Non‐small Cell Lung Cancer: A Core Dataset
Geeske F. Grit, Maaike van Dartel, Laura Rodwell, Hanneke van der Woude et al.
2026-09-07 · DOI: 10.1002/cpt.70473Constructing an External Control Arm Using the French REALYSA Cohort to Replicate Outcomes of a Randomized Trial Arm in Advanced Hodgkin Lymphoma
Olivia Febvey‐Combes, Cédric Rossi, Behrouz Kassai, Tesla Murairi Mirimo et al.
2026-09-07 · DOI: 10.1002/cpt.70470The Governance Gap: Democratizing Drug Development Through Decision Architecture
Craig R. Rayner, Nancy E. Martin, Danielle Smith, Eliza Kruger et al.
2026-09-06 · DOI: 10.1002/cpt.70476Enhancing Evidence Generation by Linking Randomized Clinical Trials to Real‐World Data: The INVESTED‐Medicare Linkage Study
Hanseul Cho, HoJin Shin, Mehdi Najafzadeh, Brian Claggett et al.
2026-09-06 · DOI: 10.1002/cpt.70457Analysis of Suffix Use for Biosimilar Product Identification in Postmarketing Adverse Event Reporting
Danijela Stojanovic, Lisa Wolf, M. Stacey Ricci, Monica A. Muñoz et al.
2026-09-06 · DOI: 10.1002/cpt.70478Physiologically Based Pharmacokinetic Modeling to Assess Transporter‐Mediated Drug–Drug Interactions in Support of Labeling Recommendations for Zavegepant Nasal Spray
Alice Ke, Ernesto Callegari, Manthena V.S. Varma, Mayur K Ladumor et al.
2026-09-04 · DOI: 10.1002/cpt.70460Special Populations in Pivotal Clinical Trials: Eligibility and Supporting Evidence for Exclusion in EMA ‐Authorised Medicines
Maja J. Jørgensen, Débora D. Gräf, Christine E. Hallgreen
2026-09-04 · DOI: 10.1002/cpt.70475Integrating Patient‐Centric Clinical Pharmacology and MID3 to Advance Biologic Development in Immune‐Mediated Inflammatory Diseases
Sihem Ait‐Oudhia, Li Zhang, Dipak S. Pisal, Brian Cicali et al.
2026-09-03 · DOI: 10.1002/cpt.70471Advances in New Approach Methodologies at FDA 's Division of Applied Regulatory Science
Ksenia Blinova, Kimberly Chiu, Anik Chaturbedi, Jahan Cooper et al.
2026-09-03 · DOI: 10.1002/cpt.70472Secondary Pharmacology Targets for Pediatric Developmental Safety Assessment of New Drugs: Clinical Pharmacology Considerations
Gilbert J. Burckart, Sherbet Samuels, Susan M. Abdel‐Rahman, Gelareh Abulwerdi et al.
2026-09-03 · DOI: 10.1002/cpt.70465AI Cautionary Guide: Pitfalls and Strategies for the Use of Machine Learning in Medical Research
Qi Liu, Ruihao Huang, Hanrui Zhang, Thomas F. Osborne et al.
2026-09-03 · DOI: 10.1002/cpt.70469Multiscale Modeling of an 8‐Week Combination Regimen of Bemnifosbuvir and Ruzasvir in Patients with Chronic Hepatitis C Virus Infection
Carolin Zitzmann, Ruy M. Ribeiro, Aurelien Marc, Xiao‐Jian Zhou et al.
2026-09-03 · DOI: 10.1002/cpt.70454Dispensing of actionable pharmacogenetic drugs among adults receiving cardiovascular disease medications in the Northern Netherlands: A serial cross‐sectional study
Zhuolin Zhang, Guiling Zhou, Jens H. J. Bos, Eelko Hak et al.
2026-09-01 · DOI: 10.1002/cpt.70461Transcriptomic Profiling of SLC and ABC Transporters in the Human Term Placenta
Elijah Marsh Jung, Nicholas Ieronimakis, Bothaina Mousa, Emily D. Sheikh et al.
2026-09-01 · DOI: 10.1002/cpt.70463Model‐Informed Approaches for Pediatric Type 2 Diabetes Evidence Generation: Insights from a Model‐Based Longitudinal HbA1c Meta‐Analysis from EMA Marketing Authorization Applications
Pieter J. Colin, Efthymios Manolis, Jeroen V. Koomen
2026-09-01 · DOI: 10.1002/cpt.70468Long‐Acting Therapeutics in Pediatric Health: Bridging Innovation and Access
Prajith Venkatasubramanian, Moherndran Archary, Daniel B. Hawcutt, Rachel Daley et al.
2026-08-28 · DOI: 10.1002/cpt.70458Reviews
Community Reviews
Version History
September 8, 2026 at 12:09 am
September 8, 2026